nodes	percent_of_prediction	percent_of_DWPC	metapath
Clopidogrel—ABCB1—ovarian cancer	0.333	1	CbGaD
Clopidogrel—ABCB1—Topotecan—ovarian cancer	0.0521	0.132	CbGbCtD
Clopidogrel—CYP3A5—Paclitaxel—ovarian cancer	0.0397	0.1	CbGbCtD
Clopidogrel—CYP2C8—Paclitaxel—ovarian cancer	0.0381	0.0964	CbGbCtD
Clopidogrel—ABCB1—Vinorelbine—ovarian cancer	0.0367	0.0928	CbGbCtD
Clopidogrel—CYP3A4—Topotecan—ovarian cancer	0.0312	0.0789	CbGbCtD
Clopidogrel—CYP3A5—Docetaxel—ovarian cancer	0.0287	0.0725	CbGbCtD
Clopidogrel—CYP2B6—Doxorubicin—ovarian cancer	0.0271	0.0686	CbGbCtD
Clopidogrel—CYP2C9—Paclitaxel—ovarian cancer	0.0266	0.0672	CbGbCtD
Clopidogrel—ABCB1—Paclitaxel—ovarian cancer	0.0258	0.0652	CbGbCtD
Clopidogrel—CYP3A4—Vinorelbine—ovarian cancer	0.022	0.0556	CbGbCtD
Clopidogrel—ABCB1—Docetaxel—ovarian cancer	0.0187	0.0472	CbGbCtD
Clopidogrel—CYP3A4—Paclitaxel—ovarian cancer	0.0155	0.0391	CbGbCtD
Clopidogrel—ABCB1—Doxorubicin—ovarian cancer	0.0139	0.0352	CbGbCtD
Clopidogrel—CYP3A4—Docetaxel—ovarian cancer	0.0112	0.0283	CbGbCtD
Clopidogrel—CYP3A4—Doxorubicin—ovarian cancer	0.00833	0.0211	CbGbCtD
Clopidogrel—Liver function test abnormal—Doxorubicin—ovarian cancer	0.000189	0.000744	CcSEcCtD
Clopidogrel—Infection—Paclitaxel—ovarian cancer	0.000189	0.000744	CcSEcCtD
Clopidogrel—Pancreatitis—Epirubicin—ovarian cancer	0.000187	0.000738	CcSEcCtD
Clopidogrel—Shock—Paclitaxel—ovarian cancer	0.000187	0.000737	CcSEcCtD
Clopidogrel—Dizziness—Vinorelbine—ovarian cancer	0.000187	0.000736	CcSEcCtD
Clopidogrel—Abdominal pain upper—Doxorubicin—ovarian cancer	0.000187	0.000736	CcSEcCtD
Clopidogrel—Nervous system disorder—Paclitaxel—ovarian cancer	0.000186	0.000734	CcSEcCtD
Clopidogrel—Angina pectoris—Epirubicin—ovarian cancer	0.000186	0.000733	CcSEcCtD
Clopidogrel—Skin disorder—Paclitaxel—ovarian cancer	0.000185	0.000727	CcSEcCtD
Clopidogrel—Toxic epidermal necrolysis—Doxorubicin—ovarian cancer	0.000184	0.000726	CcSEcCtD
Clopidogrel—Bronchitis—Epirubicin—ovarian cancer	0.000184	0.000724	CcSEcCtD
Clopidogrel—Anaemia—Docetaxel—ovarian cancer	0.000183	0.000719	CcSEcCtD
Clopidogrel—Pancytopenia—Epirubicin—ovarian cancer	0.000182	0.000715	CcSEcCtD
Clopidogrel—Gastritis—Doxorubicin—ovarian cancer	0.000181	0.000713	CcSEcCtD
Clopidogrel—Vomiting—Vinorelbine—ovarian cancer	0.00018	0.000708	CcSEcCtD
Clopidogrel—Neutropenia—Epirubicin—ovarian cancer	0.000179	0.000704	CcSEcCtD
Clopidogrel—Rash—Vinorelbine—ovarian cancer	0.000178	0.000702	CcSEcCtD
Clopidogrel—Dermatitis—Vinorelbine—ovarian cancer	0.000178	0.000701	CcSEcCtD
Clopidogrel—Abdominal distension—Doxorubicin—ovarian cancer	0.000178	0.000701	CcSEcCtD
Clopidogrel—Hypotension—Paclitaxel—ovarian cancer	0.000178	0.0007	CcSEcCtD
Clopidogrel—Upper respiratory tract infection—Epirubicin—ovarian cancer	0.000178	0.0007	CcSEcCtD
Clopidogrel—Headache—Vinorelbine—ovarian cancer	0.000177	0.000697	CcSEcCtD
Clopidogrel—Syncope—Docetaxel—ovarian cancer	0.000177	0.000697	CcSEcCtD
Clopidogrel—Asthma—Doxorubicin—ovarian cancer	0.000177	0.000696	CcSEcCtD
Clopidogrel—Leukopenia—Docetaxel—ovarian cancer	0.000177	0.000696	CcSEcCtD
Clopidogrel—Eosinophilia—Doxorubicin—ovarian cancer	0.000175	0.00069	CcSEcCtD
Clopidogrel—Palpitations—Docetaxel—ovarian cancer	0.000175	0.000687	CcSEcCtD
Clopidogrel—Loss of consciousness—Docetaxel—ovarian cancer	0.000174	0.000683	CcSEcCtD
Clopidogrel—Pancreatitis—Doxorubicin—ovarian cancer	0.000173	0.000683	CcSEcCtD
Clopidogrel—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.000173	0.000682	CcSEcCtD
Clopidogrel—Cough—Docetaxel—ovarian cancer	0.000172	0.000679	CcSEcCtD
Clopidogrel—Angina pectoris—Doxorubicin—ovarian cancer	0.000172	0.000678	CcSEcCtD
Clopidogrel—Insomnia—Paclitaxel—ovarian cancer	0.000172	0.000677	CcSEcCtD
Clopidogrel—Pneumonia—Epirubicin—ovarian cancer	0.000171	0.000675	CcSEcCtD
Clopidogrel—Paraesthesia—Paclitaxel—ovarian cancer	0.000171	0.000672	CcSEcCtD
Clopidogrel—Hypertension—Docetaxel—ovarian cancer	0.000171	0.000671	CcSEcCtD
Clopidogrel—Bronchitis—Doxorubicin—ovarian cancer	0.00017	0.00067	CcSEcCtD
Clopidogrel—Dyspnoea—Paclitaxel—ovarian cancer	0.00017	0.000668	CcSEcCtD
Clopidogrel—Stevens-Johnson syndrome—Epirubicin—ovarian cancer	0.000169	0.000665	CcSEcCtD
Clopidogrel—Arthralgia—Docetaxel—ovarian cancer	0.000168	0.000662	CcSEcCtD
Clopidogrel—Chest pain—Docetaxel—ovarian cancer	0.000168	0.000662	CcSEcCtD
Clopidogrel—Myalgia—Docetaxel—ovarian cancer	0.000168	0.000662	CcSEcCtD
Clopidogrel—Pancytopenia—Doxorubicin—ovarian cancer	0.000168	0.000661	CcSEcCtD
Clopidogrel—Nausea—Vinorelbine—ovarian cancer	0.000168	0.000661	CcSEcCtD
Clopidogrel—Renal failure—Epirubicin—ovarian cancer	0.000168	0.00066	CcSEcCtD
Clopidogrel—Dyspepsia—Paclitaxel—ovarian cancer	0.000167	0.000659	CcSEcCtD
Clopidogrel—Neuropathy peripheral—Epirubicin—ovarian cancer	0.000167	0.000658	CcSEcCtD
Clopidogrel—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.000167	0.000657	CcSEcCtD
Clopidogrel—Stomatitis—Epirubicin—ovarian cancer	0.000166	0.000654	CcSEcCtD
Clopidogrel—Urinary tract infection—Epirubicin—ovarian cancer	0.000166	0.000652	CcSEcCtD
Clopidogrel—Conjunctivitis—Epirubicin—ovarian cancer	0.000166	0.000652	CcSEcCtD
Clopidogrel—Neutropenia—Doxorubicin—ovarian cancer	0.000165	0.000651	CcSEcCtD
Clopidogrel—Upper respiratory tract infection—Doxorubicin—ovarian cancer	0.000164	0.000647	CcSEcCtD
Clopidogrel—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000164	0.000646	CcSEcCtD
Clopidogrel—Fatigue—Paclitaxel—ovarian cancer	0.000164	0.000646	CcSEcCtD
Clopidogrel—Pain—Paclitaxel—ovarian cancer	0.000163	0.00064	CcSEcCtD
Clopidogrel—Constipation—Paclitaxel—ovarian cancer	0.000163	0.00064	CcSEcCtD
Clopidogrel—Haematuria—Epirubicin—ovarian cancer	0.000163	0.00064	CcSEcCtD
Clopidogrel—Confusional state—Docetaxel—ovarian cancer	0.000163	0.00064	CcSEcCtD
Clopidogrel—Hepatobiliary disease—Epirubicin—ovarian cancer	0.000161	0.000635	CcSEcCtD
Clopidogrel—Oedema—Docetaxel—ovarian cancer	0.000161	0.000635	CcSEcCtD
Clopidogrel—Anaphylactic shock—Docetaxel—ovarian cancer	0.000161	0.000635	CcSEcCtD
Clopidogrel—Epistaxis—Epirubicin—ovarian cancer	0.000161	0.000633	CcSEcCtD
Clopidogrel—Infection—Docetaxel—ovarian cancer	0.00016	0.00063	CcSEcCtD
Clopidogrel—Sinusitis—Epirubicin—ovarian cancer	0.00016	0.00063	CcSEcCtD
Clopidogrel—Agranulocytosis—Epirubicin—ovarian cancer	0.000159	0.000626	CcSEcCtD
Clopidogrel—Pneumonia—Doxorubicin—ovarian cancer	0.000159	0.000625	CcSEcCtD
Clopidogrel—Shock—Docetaxel—ovarian cancer	0.000159	0.000624	CcSEcCtD
Clopidogrel—Nervous system disorder—Docetaxel—ovarian cancer	0.000158	0.000622	CcSEcCtD
Clopidogrel—Feeling abnormal—Paclitaxel—ovarian cancer	0.000157	0.000617	CcSEcCtD
Clopidogrel—Skin disorder—Docetaxel—ovarian cancer	0.000157	0.000616	CcSEcCtD
Clopidogrel—Stevens-Johnson syndrome—Doxorubicin—ovarian cancer	0.000156	0.000616	CcSEcCtD
Clopidogrel—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000155	0.000612	CcSEcCtD
Clopidogrel—Renal failure—Doxorubicin—ovarian cancer	0.000155	0.00061	CcSEcCtD
Clopidogrel—Neuropathy peripheral—Doxorubicin—ovarian cancer	0.000155	0.000609	CcSEcCtD
Clopidogrel—Haemoglobin—Epirubicin—ovarian cancer	0.000154	0.000606	CcSEcCtD
Clopidogrel—Stomatitis—Doxorubicin—ovarian cancer	0.000154	0.000605	CcSEcCtD
Clopidogrel—Rhinitis—Epirubicin—ovarian cancer	0.000153	0.000604	CcSEcCtD
Clopidogrel—Conjunctivitis—Doxorubicin—ovarian cancer	0.000153	0.000604	CcSEcCtD
Clopidogrel—Urinary tract infection—Doxorubicin—ovarian cancer	0.000153	0.000604	CcSEcCtD
Clopidogrel—Haemorrhage—Epirubicin—ovarian cancer	0.000153	0.000602	CcSEcCtD
Clopidogrel—Hepatitis—Epirubicin—ovarian cancer	0.000153	0.000602	CcSEcCtD
Clopidogrel—Hypoaesthesia—Epirubicin—ovarian cancer	0.000152	0.000599	CcSEcCtD
Clopidogrel—Urinary tract disorder—Epirubicin—ovarian cancer	0.000151	0.000595	CcSEcCtD
Clopidogrel—Urticaria—Paclitaxel—ovarian cancer	0.000151	0.000595	CcSEcCtD
Clopidogrel—Oedema peripheral—Epirubicin—ovarian cancer	0.000151	0.000594	CcSEcCtD
Clopidogrel—Hypotension—Docetaxel—ovarian cancer	0.000151	0.000593	CcSEcCtD
Clopidogrel—Haematuria—Doxorubicin—ovarian cancer	0.00015	0.000592	CcSEcCtD
Clopidogrel—Body temperature increased—Paclitaxel—ovarian cancer	0.00015	0.000592	CcSEcCtD
Clopidogrel—Abdominal pain—Paclitaxel—ovarian cancer	0.00015	0.000592	CcSEcCtD
Clopidogrel—Urethral disorder—Epirubicin—ovarian cancer	0.00015	0.000591	CcSEcCtD
Clopidogrel—Hepatobiliary disease—Doxorubicin—ovarian cancer	0.000149	0.000587	CcSEcCtD
Clopidogrel—Epistaxis—Doxorubicin—ovarian cancer	0.000149	0.000586	CcSEcCtD
Clopidogrel—Sinusitis—Doxorubicin—ovarian cancer	0.000148	0.000583	CcSEcCtD
Clopidogrel—Visual impairment—Epirubicin—ovarian cancer	0.000147	0.000581	CcSEcCtD
Clopidogrel—Agranulocytosis—Doxorubicin—ovarian cancer	0.000147	0.00058	CcSEcCtD
Clopidogrel—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000147	0.000578	CcSEcCtD
Clopidogrel—Insomnia—Docetaxel—ovarian cancer	0.000146	0.000574	CcSEcCtD
Clopidogrel—Paraesthesia—Docetaxel—ovarian cancer	0.000145	0.00057	CcSEcCtD
Clopidogrel—Erythema multiforme—Epirubicin—ovarian cancer	0.000145	0.00057	CcSEcCtD
Clopidogrel—Dyspnoea—Docetaxel—ovarian cancer	0.000144	0.000566	CcSEcCtD
Clopidogrel—Eye disorder—Epirubicin—ovarian cancer	0.000143	0.000563	CcSEcCtD
Clopidogrel—Tinnitus—Epirubicin—ovarian cancer	0.000143	0.000562	CcSEcCtD
Clopidogrel—Haemoglobin—Doxorubicin—ovarian cancer	0.000142	0.00056	CcSEcCtD
Clopidogrel—Rhinitis—Doxorubicin—ovarian cancer	0.000142	0.000559	CcSEcCtD
Clopidogrel—Dyspepsia—Docetaxel—ovarian cancer	0.000142	0.000559	CcSEcCtD
Clopidogrel—Haemorrhage—Doxorubicin—ovarian cancer	0.000142	0.000557	CcSEcCtD
Clopidogrel—Hepatitis—Doxorubicin—ovarian cancer	0.000142	0.000557	CcSEcCtD
Clopidogrel—Hypoaesthesia—Doxorubicin—ovarian cancer	0.000141	0.000555	CcSEcCtD
Clopidogrel—Hypersensitivity—Paclitaxel—ovarian cancer	0.00014	0.000552	CcSEcCtD
Clopidogrel—Urinary tract disorder—Doxorubicin—ovarian cancer	0.00014	0.000551	CcSEcCtD
Clopidogrel—Oedema peripheral—Doxorubicin—ovarian cancer	0.000139	0.000549	CcSEcCtD
Clopidogrel—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000139	0.000548	CcSEcCtD
Clopidogrel—Fatigue—Docetaxel—ovarian cancer	0.000139	0.000547	CcSEcCtD
Clopidogrel—Angiopathy—Epirubicin—ovarian cancer	0.000139	0.000547	CcSEcCtD
Clopidogrel—Urethral disorder—Doxorubicin—ovarian cancer	0.000139	0.000546	CcSEcCtD
Clopidogrel—Immune system disorder—Epirubicin—ovarian cancer	0.000138	0.000544	CcSEcCtD
Clopidogrel—Mediastinal disorder—Epirubicin—ovarian cancer	0.000138	0.000543	CcSEcCtD
Clopidogrel—Pain—Docetaxel—ovarian cancer	0.000138	0.000543	CcSEcCtD
Clopidogrel—Constipation—Docetaxel—ovarian cancer	0.000138	0.000543	CcSEcCtD
Clopidogrel—Visual impairment—Doxorubicin—ovarian cancer	0.000136	0.000537	CcSEcCtD
Clopidogrel—Asthenia—Paclitaxel—ovarian cancer	0.000136	0.000537	CcSEcCtD
Clopidogrel—Pruritus—Paclitaxel—ovarian cancer	0.000135	0.00053	CcSEcCtD
Clopidogrel—Mental disorder—Epirubicin—ovarian cancer	0.000134	0.000528	CcSEcCtD
Clopidogrel—Erythema multiforme—Doxorubicin—ovarian cancer	0.000134	0.000527	CcSEcCtD
Clopidogrel—Malnutrition—Epirubicin—ovarian cancer	0.000133	0.000524	CcSEcCtD
Clopidogrel—Feeling abnormal—Docetaxel—ovarian cancer	0.000133	0.000523	CcSEcCtD
Clopidogrel—Eye disorder—Doxorubicin—ovarian cancer	0.000132	0.000521	CcSEcCtD
Clopidogrel—Tinnitus—Doxorubicin—ovarian cancer	0.000132	0.00052	CcSEcCtD
Clopidogrel—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000132	0.000519	CcSEcCtD
Clopidogrel—Flatulence—Epirubicin—ovarian cancer	0.000131	0.000517	CcSEcCtD
Clopidogrel—Diarrhoea—Paclitaxel—ovarian cancer	0.00013	0.000512	CcSEcCtD
Clopidogrel—Back pain—Epirubicin—ovarian cancer	0.000129	0.000507	CcSEcCtD
Clopidogrel—Angiopathy—Doxorubicin—ovarian cancer	0.000128	0.000506	CcSEcCtD
Clopidogrel—Muscle spasms—Epirubicin—ovarian cancer	0.000128	0.000504	CcSEcCtD
Clopidogrel—Immune system disorder—Doxorubicin—ovarian cancer	0.000128	0.000504	CcSEcCtD
Clopidogrel—Mediastinal disorder—Doxorubicin—ovarian cancer	0.000128	0.000502	CcSEcCtD
Clopidogrel—Abdominal pain—Docetaxel—ovarian cancer	0.000127	0.000502	CcSEcCtD
Clopidogrel—Body temperature increased—Docetaxel—ovarian cancer	0.000127	0.000502	CcSEcCtD
Clopidogrel—Dizziness—Paclitaxel—ovarian cancer	0.000126	0.000495	CcSEcCtD
Clopidogrel—Mental disorder—Doxorubicin—ovarian cancer	0.000124	0.000488	CcSEcCtD
Clopidogrel—Malnutrition—Doxorubicin—ovarian cancer	0.000123	0.000485	CcSEcCtD
Clopidogrel—Anaemia—Epirubicin—ovarian cancer	0.000123	0.000485	CcSEcCtD
Clopidogrel—Flatulence—Doxorubicin—ovarian cancer	0.000121	0.000478	CcSEcCtD
Clopidogrel—Vomiting—Paclitaxel—ovarian cancer	0.000121	0.000476	CcSEcCtD
Clopidogrel—Rash—Paclitaxel—ovarian cancer	0.00012	0.000472	CcSEcCtD
Clopidogrel—Dermatitis—Paclitaxel—ovarian cancer	0.00012	0.000472	CcSEcCtD
Clopidogrel—Vertigo—Epirubicin—ovarian cancer	0.00012	0.000471	CcSEcCtD
Clopidogrel—Syncope—Epirubicin—ovarian cancer	0.000119	0.00047	CcSEcCtD
Clopidogrel—Leukopenia—Epirubicin—ovarian cancer	0.000119	0.000469	CcSEcCtD
Clopidogrel—Back pain—Doxorubicin—ovarian cancer	0.000119	0.000469	CcSEcCtD
Clopidogrel—Headache—Paclitaxel—ovarian cancer	0.000119	0.000469	CcSEcCtD
Clopidogrel—Hypersensitivity—Docetaxel—ovarian cancer	0.000119	0.000468	CcSEcCtD
Clopidogrel—Muscle spasms—Doxorubicin—ovarian cancer	0.000119	0.000467	CcSEcCtD
Clopidogrel—Palpitations—Epirubicin—ovarian cancer	0.000118	0.000463	CcSEcCtD
Clopidogrel—Loss of consciousness—Epirubicin—ovarian cancer	0.000117	0.000461	CcSEcCtD
Clopidogrel—Cough—Epirubicin—ovarian cancer	0.000116	0.000458	CcSEcCtD
Clopidogrel—Asthenia—Docetaxel—ovarian cancer	0.000116	0.000455	CcSEcCtD
Clopidogrel—Hypertension—Epirubicin—ovarian cancer	0.000115	0.000453	CcSEcCtD
Clopidogrel—Pruritus—Docetaxel—ovarian cancer	0.000114	0.000449	CcSEcCtD
Clopidogrel—Anaemia—Doxorubicin—ovarian cancer	0.000114	0.000449	CcSEcCtD
Clopidogrel—Chest pain—Epirubicin—ovarian cancer	0.000113	0.000447	CcSEcCtD
Clopidogrel—Arthralgia—Epirubicin—ovarian cancer	0.000113	0.000447	CcSEcCtD
Clopidogrel—Myalgia—Epirubicin—ovarian cancer	0.000113	0.000447	CcSEcCtD
Clopidogrel—Anxiety—Epirubicin—ovarian cancer	0.000113	0.000445	CcSEcCtD
Clopidogrel—Nausea—Paclitaxel—ovarian cancer	0.000113	0.000445	CcSEcCtD
Clopidogrel—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.000113	0.000443	CcSEcCtD
Clopidogrel—Vertigo—Doxorubicin—ovarian cancer	0.000111	0.000436	CcSEcCtD
Clopidogrel—Syncope—Doxorubicin—ovarian cancer	0.000111	0.000435	CcSEcCtD
Clopidogrel—Leukopenia—Doxorubicin—ovarian cancer	0.00011	0.000434	CcSEcCtD
Clopidogrel—Diarrhoea—Docetaxel—ovarian cancer	0.00011	0.000434	CcSEcCtD
Clopidogrel—Confusional state—Epirubicin—ovarian cancer	0.00011	0.000432	CcSEcCtD
Clopidogrel—Palpitations—Doxorubicin—ovarian cancer	0.000109	0.000429	CcSEcCtD
Clopidogrel—Oedema—Epirubicin—ovarian cancer	0.000109	0.000428	CcSEcCtD
Clopidogrel—Anaphylactic shock—Epirubicin—ovarian cancer	0.000109	0.000428	CcSEcCtD
Clopidogrel—Loss of consciousness—Doxorubicin—ovarian cancer	0.000108	0.000427	CcSEcCtD
Clopidogrel—Infection—Epirubicin—ovarian cancer	0.000108	0.000425	CcSEcCtD
Clopidogrel—Cough—Doxorubicin—ovarian cancer	0.000108	0.000423	CcSEcCtD
Clopidogrel—Shock—Epirubicin—ovarian cancer	0.000107	0.000421	CcSEcCtD
Clopidogrel—Nervous system disorder—Epirubicin—ovarian cancer	0.000107	0.00042	CcSEcCtD
Clopidogrel—Dizziness—Docetaxel—ovarian cancer	0.000107	0.00042	CcSEcCtD
Clopidogrel—Hypertension—Doxorubicin—ovarian cancer	0.000106	0.000419	CcSEcCtD
Clopidogrel—Skin disorder—Epirubicin—ovarian cancer	0.000106	0.000416	CcSEcCtD
Clopidogrel—Arthralgia—Doxorubicin—ovarian cancer	0.000105	0.000413	CcSEcCtD
Clopidogrel—Myalgia—Doxorubicin—ovarian cancer	0.000105	0.000413	CcSEcCtD
Clopidogrel—Chest pain—Doxorubicin—ovarian cancer	0.000105	0.000413	CcSEcCtD
Clopidogrel—Anxiety—Doxorubicin—ovarian cancer	0.000105	0.000412	CcSEcCtD
Clopidogrel—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.000104	0.00041	CcSEcCtD
Clopidogrel—Vomiting—Docetaxel—ovarian cancer	0.000102	0.000404	CcSEcCtD
Clopidogrel—Rash—Docetaxel—ovarian cancer	0.000102	0.0004	CcSEcCtD
Clopidogrel—Hypotension—Epirubicin—ovarian cancer	0.000102	0.0004	CcSEcCtD
Clopidogrel—Dermatitis—Docetaxel—ovarian cancer	0.000102	0.0004	CcSEcCtD
Clopidogrel—Confusional state—Doxorubicin—ovarian cancer	0.000101	0.000399	CcSEcCtD
Clopidogrel—Headache—Docetaxel—ovarian cancer	0.000101	0.000398	CcSEcCtD
Clopidogrel—Anaphylactic shock—Doxorubicin—ovarian cancer	0.000101	0.000396	CcSEcCtD
Clopidogrel—Oedema—Doxorubicin—ovarian cancer	0.000101	0.000396	CcSEcCtD
Clopidogrel—Infection—Doxorubicin—ovarian cancer	9.99e-05	0.000393	CcSEcCtD
Clopidogrel—Musculoskeletal discomfort—Epirubicin—ovarian cancer	9.9e-05	0.00039	CcSEcCtD
Clopidogrel—Shock—Doxorubicin—ovarian cancer	9.9e-05	0.00039	CcSEcCtD
Clopidogrel—Nervous system disorder—Doxorubicin—ovarian cancer	9.86e-05	0.000388	CcSEcCtD
Clopidogrel—Insomnia—Epirubicin—ovarian cancer	9.83e-05	0.000387	CcSEcCtD
Clopidogrel—Skin disorder—Doxorubicin—ovarian cancer	9.77e-05	0.000385	CcSEcCtD
Clopidogrel—Paraesthesia—Epirubicin—ovarian cancer	9.76e-05	0.000384	CcSEcCtD
Clopidogrel—Dyspnoea—Epirubicin—ovarian cancer	9.69e-05	0.000382	CcSEcCtD
Clopidogrel—Nausea—Docetaxel—ovarian cancer	9.57e-05	0.000377	CcSEcCtD
Clopidogrel—Dyspepsia—Epirubicin—ovarian cancer	9.57e-05	0.000377	CcSEcCtD
Clopidogrel—Hypotension—Doxorubicin—ovarian cancer	9.4e-05	0.00037	CcSEcCtD
Clopidogrel—Gastrointestinal disorder—Epirubicin—ovarian cancer	9.39e-05	0.00037	CcSEcCtD
Clopidogrel—Fatigue—Epirubicin—ovarian cancer	9.37e-05	0.000369	CcSEcCtD
Clopidogrel—Pain—Epirubicin—ovarian cancer	9.3e-05	0.000366	CcSEcCtD
Clopidogrel—Constipation—Epirubicin—ovarian cancer	9.3e-05	0.000366	CcSEcCtD
Clopidogrel—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	9.16e-05	0.000361	CcSEcCtD
Clopidogrel—Insomnia—Doxorubicin—ovarian cancer	9.1e-05	0.000358	CcSEcCtD
Clopidogrel—Paraesthesia—Doxorubicin—ovarian cancer	9.03e-05	0.000356	CcSEcCtD
Clopidogrel—Dyspnoea—Doxorubicin—ovarian cancer	8.97e-05	0.000353	CcSEcCtD
Clopidogrel—Feeling abnormal—Epirubicin—ovarian cancer	8.96e-05	0.000353	CcSEcCtD
Clopidogrel—Gastrointestinal pain—Epirubicin—ovarian cancer	8.89e-05	0.00035	CcSEcCtD
Clopidogrel—Dyspepsia—Doxorubicin—ovarian cancer	8.85e-05	0.000349	CcSEcCtD
Clopidogrel—Gastrointestinal disorder—Doxorubicin—ovarian cancer	8.68e-05	0.000342	CcSEcCtD
Clopidogrel—Fatigue—Doxorubicin—ovarian cancer	8.67e-05	0.000341	CcSEcCtD
Clopidogrel—Urticaria—Epirubicin—ovarian cancer	8.64e-05	0.00034	CcSEcCtD
Clopidogrel—Constipation—Doxorubicin—ovarian cancer	8.6e-05	0.000339	CcSEcCtD
Clopidogrel—Pain—Doxorubicin—ovarian cancer	8.6e-05	0.000339	CcSEcCtD
Clopidogrel—Body temperature increased—Epirubicin—ovarian cancer	8.59e-05	0.000338	CcSEcCtD
Clopidogrel—Abdominal pain—Epirubicin—ovarian cancer	8.59e-05	0.000338	CcSEcCtD
Clopidogrel—Feeling abnormal—Doxorubicin—ovarian cancer	8.29e-05	0.000326	CcSEcCtD
Clopidogrel—Gastrointestinal pain—Doxorubicin—ovarian cancer	8.23e-05	0.000324	CcSEcCtD
Clopidogrel—Hypersensitivity—Epirubicin—ovarian cancer	8.01e-05	0.000315	CcSEcCtD
Clopidogrel—Urticaria—Doxorubicin—ovarian cancer	7.99e-05	0.000315	CcSEcCtD
Clopidogrel—Body temperature increased—Doxorubicin—ovarian cancer	7.95e-05	0.000313	CcSEcCtD
Clopidogrel—Abdominal pain—Doxorubicin—ovarian cancer	7.95e-05	0.000313	CcSEcCtD
Clopidogrel—Asthenia—Epirubicin—ovarian cancer	7.8e-05	0.000307	CcSEcCtD
Clopidogrel—Pruritus—Epirubicin—ovarian cancer	7.69e-05	0.000303	CcSEcCtD
Clopidogrel—Diarrhoea—Epirubicin—ovarian cancer	7.44e-05	0.000293	CcSEcCtD
Clopidogrel—Hypersensitivity—Doxorubicin—ovarian cancer	7.41e-05	0.000292	CcSEcCtD
Clopidogrel—Asthenia—Doxorubicin—ovarian cancer	7.22e-05	0.000284	CcSEcCtD
Clopidogrel—Dizziness—Epirubicin—ovarian cancer	7.19e-05	0.000283	CcSEcCtD
Clopidogrel—Pruritus—Doxorubicin—ovarian cancer	7.12e-05	0.00028	CcSEcCtD
Clopidogrel—Vomiting—Epirubicin—ovarian cancer	6.91e-05	0.000272	CcSEcCtD
Clopidogrel—Diarrhoea—Doxorubicin—ovarian cancer	6.88e-05	0.000271	CcSEcCtD
Clopidogrel—Rash—Epirubicin—ovarian cancer	6.85e-05	0.00027	CcSEcCtD
Clopidogrel—Dermatitis—Epirubicin—ovarian cancer	6.85e-05	0.00027	CcSEcCtD
Clopidogrel—Headache—Epirubicin—ovarian cancer	6.81e-05	0.000268	CcSEcCtD
Clopidogrel—Dizziness—Doxorubicin—ovarian cancer	6.65e-05	0.000262	CcSEcCtD
Clopidogrel—Nausea—Epirubicin—ovarian cancer	6.46e-05	0.000254	CcSEcCtD
Clopidogrel—Vomiting—Doxorubicin—ovarian cancer	6.4e-05	0.000252	CcSEcCtD
Clopidogrel—Rash—Doxorubicin—ovarian cancer	6.34e-05	0.00025	CcSEcCtD
Clopidogrel—Dermatitis—Doxorubicin—ovarian cancer	6.34e-05	0.000249	CcSEcCtD
Clopidogrel—Headache—Doxorubicin—ovarian cancer	6.3e-05	0.000248	CcSEcCtD
Clopidogrel—Nausea—Doxorubicin—ovarian cancer	5.98e-05	0.000235	CcSEcCtD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—APC—ovarian cancer	1.66e-05	0.000941	CbGpPWpGaD
Clopidogrel—P2RY12—Hemostasis—PIK3CA—ovarian cancer	1.63e-05	0.000927	CbGpPWpGaD
Clopidogrel—P2RY12—GPCR downstream signaling—CXCL8—ovarian cancer	1.63e-05	0.000923	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—CYTB—ovarian cancer	1.62e-05	0.000918	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	1.61e-05	0.000913	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—CYTB—ovarian cancer	1.58e-05	0.000897	CbGpPWpGaD
Clopidogrel—P2RY12—Hemostasis—TP53—ovarian cancer	1.58e-05	0.000897	CbGpPWpGaD
Clopidogrel—P2RY12—GPCR downstream signaling—IL2—ovarian cancer	1.56e-05	0.000882	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling by GPCR—PIK3CB—ovarian cancer	1.54e-05	0.000872	CbGpPWpGaD
Clopidogrel—P2RY12—Hemostasis—HRAS—ovarian cancer	1.51e-05	0.000857	CbGpPWpGaD
Clopidogrel—ABCB1—HIF-1-alpha transcription factor network—AKT1—ovarian cancer	1.48e-05	0.00084	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—NME2—ovarian cancer	1.48e-05	0.000839	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling by GPCR—CXCL8—ovarian cancer	1.48e-05	0.000838	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	1.47e-05	0.000834	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	1.47e-05	0.000833	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—PPP1CC—ovarian cancer	1.41e-05	0.000802	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—BRIP1—ovarian cancer	1.41e-05	0.000802	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling by GPCR—IL2—ovarian cancer	1.41e-05	0.000801	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—TERT—ovarian cancer	1.41e-05	0.000798	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—PPP1CC—ovarian cancer	1.38e-05	0.000784	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—BRIP1—ovarian cancer	1.38e-05	0.000784	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—CYTB—ovarian cancer	1.37e-05	0.000777	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	1.34e-05	0.00076	CbGpPWpGaD
Clopidogrel—P2RY12—Hemostasis—AKT1—ovarian cancer	1.33e-05	0.000757	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	1.31e-05	0.000744	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—CAV1—ovarian cancer	1.3e-05	0.000738	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—ovarian cancer	1.29e-05	0.00073	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—ESR1—ovarian cancer	1.25e-05	0.000712	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	1.25e-05	0.000712	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—IL6ST—ovarian cancer	1.23e-05	0.0007	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—CYTB—ovarian cancer	1.22e-05	0.000694	CbGpPWpGaD
Clopidogrel—ABCB1—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	1.2e-05	0.00068	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—BRIP1—ovarian cancer	1.2e-05	0.000679	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—PPP1CC—ovarian cancer	1.2e-05	0.000679	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	1.2e-05	0.000679	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	1.2e-05	0.000678	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—CYTB—ovarian cancer	1.19e-05	0.000677	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—ovarian cancer	1.19e-05	0.000676	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—APC—ovarian cancer	1.19e-05	0.000673	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—PIK3CG—ovarian cancer	1.19e-05	0.000673	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling by GPCR—NRAS—ovarian cancer	1.19e-05	0.000673	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—ovarian cancer	1.17e-05	0.000663	CbGpPWpGaD
Clopidogrel—ABCB1—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	1.16e-05	0.000656	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—NME2—ovarian cancer	1.14e-05	0.000647	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—ovarian cancer	1.14e-05	0.000645	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling by GPCR—MAPK3—ovarian cancer	1.14e-05	0.000644	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—ovarian cancer	1.13e-05	0.000639	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—CYTB—ovarian cancer	1.12e-05	0.000633	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—ovarian cancer	1.1e-05	0.000623	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	1.09e-05	0.000618	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling by GPCR—MAPK1—ovarian cancer	1.08e-05	0.000613	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling by GPCR—EGFR—ovarian cancer	1.08e-05	0.000613	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—BRIP1—ovarian cancer	1.07e-05	0.000606	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—PPP1CC—ovarian cancer	1.07e-05	0.000606	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—BRIP1—ovarian cancer	1.04e-05	0.000592	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—PPP1CC—ovarian cancer	1.04e-05	0.000592	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—PIK3CD—ovarian cancer	1.04e-05	0.000591	CbGpPWpGaD
Clopidogrel—P2RY12—GPCR downstream signaling—PIK3CA—ovarian cancer	1.03e-05	0.000586	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	1.02e-05	0.00058	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling by GPCR—KRAS—ovarian cancer	1.02e-05	0.000579	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—ovarian cancer	9.92e-06	0.000563	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—PPP1CC—ovarian cancer	9.75e-06	0.000553	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—BRIP1—ovarian cancer	9.75e-06	0.000553	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—CYTB—ovarian cancer	9.53e-06	0.000541	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—YAP1—ovarian cancer	9.49e-06	0.000538	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—ovarian cancer	9.38e-06	0.000532	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling by GPCR—PIK3CA—ovarian cancer	9.38e-06	0.000532	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	9.32e-06	0.000528	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—YAP1—ovarian cancer	9.28e-06	0.000526	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—ERBB2—ovarian cancer	9.21e-06	0.000522	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—ovarian cancer	9.13e-06	0.000518	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—PIK3CB—ovarian cancer	9.09e-06	0.000515	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—MTOR—ovarian cancer	9.09e-06	0.000515	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—ovarian cancer	8.93e-06	0.000506	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—ovarian cancer	8.93e-06	0.000506	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—CXCL8—ovarian cancer	8.73e-06	0.000495	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	8.73e-06	0.000495	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling by GPCR—HRAS—ovarian cancer	8.68e-06	0.000492	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—CDKN1B—ovarian cancer	8.53e-06	0.000484	CbGpPWpGaD
Clopidogrel—P2RY12—GPCR downstream signaling—AKT1—ovarian cancer	8.44e-06	0.000478	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—ovarian cancer	8.43e-06	0.000478	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—CASP3—ovarian cancer	8.36e-06	0.000474	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—IL2—ovarian cancer	8.35e-06	0.000473	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—BRIP1—ovarian cancer	8.33e-06	0.000472	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—PPP1CC—ovarian cancer	8.33e-06	0.000472	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling by GPCR—IL6—ovarian cancer	8.3e-06	0.000471	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—CCND1—ovarian cancer	8.14e-06	0.000461	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—CTNNB1—ovarian cancer	8.06e-06	0.000457	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—YAP1—ovarian cancer	8.03e-06	0.000456	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	7.95e-06	0.000451	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—MMP9—ovarian cancer	7.9e-06	0.000448	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—PTEN—ovarian cancer	7.85e-06	0.000445	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	7.79e-06	0.000442	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—ovarian cancer	7.75e-06	0.000439	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—FASN—ovarian cancer	7.74e-06	0.000439	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling by GPCR—AKT1—ovarian cancer	7.66e-06	0.000434	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—SLC5A5—ovarian cancer	7.61e-06	0.000432	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—FASN—ovarian cancer	7.56e-06	0.000429	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	7.5e-06	0.000425	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—SLC5A5—ovarian cancer	7.44e-06	0.000422	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—CYTB—ovarian cancer	7.36e-06	0.000417	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—SLC2A1—ovarian cancer	7.35e-06	0.000417	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—SLC2A1—ovarian cancer	7.18e-06	0.000407	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—YAP1—ovarian cancer	7.17e-06	0.000407	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	7.1e-06	0.000403	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	7.1e-06	0.000402	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—VEGFA—ovarian cancer	7.09e-06	0.000402	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—CYP1B1—ovarian cancer	7.05e-06	0.0004	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—STAT3—ovarian cancer	7.02e-06	0.000398	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—NRAS—ovarian cancer	7.01e-06	0.000397	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—YAP1—ovarian cancer	7e-06	0.000397	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	6.99e-06	0.000396	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—CYP1B1—ovarian cancer	6.89e-06	0.000391	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—MAPK3—ovarian cancer	6.71e-06	0.000381	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—FASN—ovarian cancer	6.55e-06	0.000371	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—YAP1—ovarian cancer	6.54e-06	0.000371	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—MYC—ovarian cancer	6.53e-06	0.00037	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	6.47e-06	0.000367	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—SLC5A5—ovarian cancer	6.44e-06	0.000365	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—PPP1CC—ovarian cancer	6.43e-06	0.000365	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—BRIP1—ovarian cancer	6.43e-06	0.000365	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—MAPK1—ovarian cancer	6.38e-06	0.000362	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—EGFR—ovarian cancer	6.38e-06	0.000362	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	6.33e-06	0.000359	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—PPP2R1A—ovarian cancer	6.25e-06	0.000354	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	6.24e-06	0.000354	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—SLC2A1—ovarian cancer	6.22e-06	0.000353	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—PPP2R1A—ovarian cancer	6.11e-06	0.000346	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	6.09e-06	0.000346	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	6.07e-06	0.000344	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—KRAS—ovarian cancer	6.03e-06	0.000342	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—CYP1B1—ovarian cancer	5.96e-06	0.000338	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—FASN—ovarian cancer	5.85e-06	0.000332	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—ABCB1—ovarian cancer	5.8e-06	0.000329	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—SLC5A5—ovarian cancer	5.75e-06	0.000326	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—FASN—ovarian cancer	5.71e-06	0.000324	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—TYMS—ovarian cancer	5.7e-06	0.000323	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	5.69e-06	0.000323	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—ABCB1—ovarian cancer	5.67e-06	0.000322	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—SLC5A5—ovarian cancer	5.61e-06	0.000318	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—YAP1—ovarian cancer	5.59e-06	0.000317	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—TYMS—ovarian cancer	5.57e-06	0.000316	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—SLC2A1—ovarian cancer	5.55e-06	0.000315	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—PIK3CA—ovarian cancer	5.54e-06	0.000314	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	5.53e-06	0.000314	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	5.44e-06	0.000308	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—SLC2A1—ovarian cancer	5.42e-06	0.000307	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—TP53—ovarian cancer	5.36e-06	0.000304	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—FASN—ovarian cancer	5.33e-06	0.000302	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—CYP1B1—ovarian cancer	5.32e-06	0.000302	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—PPP2R1A—ovarian cancer	5.29e-06	0.0003	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	5.26e-06	0.000299	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—SLC5A5—ovarian cancer	5.24e-06	0.000297	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—CYP1B1—ovarian cancer	5.2e-06	0.000295	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—HRAS—ovarian cancer	5.13e-06	0.000291	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—SLC2A1—ovarian cancer	5.06e-06	0.000287	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	4.96e-06	0.000281	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—ABCB1—ovarian cancer	4.91e-06	0.000279	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—IL6—ovarian cancer	4.91e-06	0.000278	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	4.86e-06	0.000276	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—CYP1B1—ovarian cancer	4.85e-06	0.000275	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—TYMS—ovarian cancer	4.82e-06	0.000274	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—PPP2R1A—ovarian cancer	4.72e-06	0.000268	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	4.7e-06	0.000266	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—PPP2R1A—ovarian cancer	4.61e-06	0.000261	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—CAV1—ovarian cancer	4.59e-06	0.00026	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—FASN—ovarian cancer	4.55e-06	0.000258	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—AKT1—ovarian cancer	4.53e-06	0.000257	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—CAV1—ovarian cancer	4.49e-06	0.000255	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—SLC5A5—ovarian cancer	4.48e-06	0.000254	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—ABCB1—ovarian cancer	4.38e-06	0.000249	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—SLC2A1—ovarian cancer	4.33e-06	0.000245	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—YAP1—ovarian cancer	4.31e-06	0.000245	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—TYMS—ovarian cancer	4.31e-06	0.000244	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—PPP2R1A—ovarian cancer	4.31e-06	0.000244	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	4.28e-06	0.000243	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	4.24e-06	0.00024	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—TYMS—ovarian cancer	4.2e-06	0.000238	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—PIK3CG—ovarian cancer	4.18e-06	0.000237	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—CYP1B1—ovarian cancer	4.15e-06	0.000235	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—PIK3CG—ovarian cancer	4.09e-06	0.000232	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—ABCB1—ovarian cancer	4e-06	0.000227	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—TYMS—ovarian cancer	3.93e-06	0.000223	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—CAV1—ovarian cancer	3.89e-06	0.00022	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	3.71e-06	0.000211	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—PPP2R1A—ovarian cancer	3.68e-06	0.000209	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—PIK3CD—ovarian cancer	3.68e-06	0.000209	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	3.66e-06	0.000208	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—PIK3CD—ovarian cancer	3.59e-06	0.000204	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—PIK3CG—ovarian cancer	3.54e-06	0.000201	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—FASN—ovarian cancer	3.52e-06	0.000199	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—CAV1—ovarian cancer	3.47e-06	0.000197	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—SLC5A5—ovarian cancer	3.46e-06	0.000196	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—ABCB1—ovarian cancer	3.42e-06	0.000194	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—CAV1—ovarian cancer	3.39e-06	0.000192	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—TYMS—ovarian cancer	3.36e-06	0.00019	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—SLC2A1—ovarian cancer	3.34e-06	0.000189	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	3.31e-06	0.000188	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—PIK3CB—ovarian cancer	3.2e-06	0.000182	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—CYP1B1—ovarian cancer	3.2e-06	0.000182	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—CAV1—ovarian cancer	3.16e-06	0.000179	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—PIK3CG—ovarian cancer	3.16e-06	0.000179	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—PIK3CB—ovarian cancer	3.13e-06	0.000178	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—PIK3CD—ovarian cancer	3.11e-06	0.000177	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—PIK3CG—ovarian cancer	3.08e-06	0.000175	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	3.02e-06	0.000171	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—PIK3CG—ovarian cancer	2.88e-06	0.000163	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	2.84e-06	0.000161	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—PIK3CD—ovarian cancer	2.78e-06	0.000158	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—PTEN—ovarian cancer	2.77e-06	0.000157	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—PIK3CB—ovarian cancer	2.71e-06	0.000154	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—PIK3CD—ovarian cancer	2.71e-06	0.000154	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—PTEN—ovarian cancer	2.71e-06	0.000154	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—CAV1—ovarian cancer	2.7e-06	0.000153	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—ABCB1—ovarian cancer	2.64e-06	0.00015	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—TYMS—ovarian cancer	2.59e-06	0.000147	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	2.58e-06	0.000146	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—PIK3CD—ovarian cancer	2.53e-06	0.000144	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—PIK3CG—ovarian cancer	2.46e-06	0.00014	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—PIK3CB—ovarian cancer	2.42e-06	0.000137	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—PIK3CB—ovarian cancer	2.36e-06	0.000134	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—PTEN—ovarian cancer	2.34e-06	0.000133	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—PIK3CB—ovarian cancer	2.21e-06	0.000125	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—PIK3CD—ovarian cancer	2.16e-06	0.000123	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—PTEN—ovarian cancer	2.09e-06	0.000119	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—CAV1—ovarian cancer	2.09e-06	0.000118	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—PTEN—ovarian cancer	2.04e-06	0.000116	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—PIK3CA—ovarian cancer	1.95e-06	0.000111	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—PIK3CA—ovarian cancer	1.91e-06	0.000108	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—PTEN—ovarian cancer	1.91e-06	0.000108	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—PIK3CG—ovarian cancer	1.9e-06	0.000108	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—PIK3CB—ovarian cancer	1.89e-06	0.000107	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—PIK3CD—ovarian cancer	1.67e-06	9.48e-05	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—PIK3CA—ovarian cancer	1.65e-06	9.38e-05	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—PTEN—ovarian cancer	1.63e-06	9.25e-05	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—AKT1—ovarian cancer	1.6e-06	9.05e-05	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—AKT1—ovarian cancer	1.56e-06	8.85e-05	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—PIK3CA—ovarian cancer	1.48e-06	8.37e-05	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—PIK3CB—ovarian cancer	1.46e-06	8.26e-05	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—PIK3CA—ovarian cancer	1.44e-06	8.17e-05	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—AKT1—ovarian cancer	1.35e-06	7.66e-05	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—PIK3CA—ovarian cancer	1.35e-06	7.63e-05	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—PTEN—ovarian cancer	1.26e-06	7.14e-05	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—AKT1—ovarian cancer	1.21e-06	6.84e-05	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—AKT1—ovarian cancer	1.18e-06	6.68e-05	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—PIK3CA—ovarian cancer	1.15e-06	6.52e-05	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—AKT1—ovarian cancer	1.1e-06	6.24e-05	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—AKT1—ovarian cancer	9.4e-07	5.33e-05	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—PIK3CA—ovarian cancer	8.88e-07	5.03e-05	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—AKT1—ovarian cancer	7.25e-07	4.11e-05	CbGpPWpGaD
